1. RARE-13. CHARACTERISTICS AND TREATMENT PATTERNS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMAS (PN): A CROSS-SECTIONAL ANALYSIS OF CHILDREN'S TUMOR FOUNDATION (CTF) REGISTRY DATA. (11th November 2019) Authors: He, Jinghua; Anne Pinto, Cathy; Yang, Xiaoqin; Diede, Scott; Deitz, Anne Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 429 Long-term analysis of MASTERKEY-265 phase 1b trial of talimogene laherparepvec (T-VEC) plus pembrolizumab in patients with unresectable stage IIIB-IVM1c melanoma. (9th November 2020) Authors: Long, Georgina; Dummer, Reinhard; Johnson, Douglas; Michielin, Olivier; Martin-Algarra, Salvador; Treichel, Sheryl; Chan, Edward; Diede, Scott; Ribas, Antoni Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 429 Long-term analysis of MASTERKEY-265 phase 1b trial of talimogene laherparepvec (T-VEC) plus pembrolizumab in patients with unresectable stage IIIB-IVM1c melanoma. (9th November 2020) Authors: Long, Georgina; Dummer, Reinhard; Johnson, Douglas; Michielin, Olivier; Martin-Algarra, Salvador; Treichel, Sheryl; Chan, Edward; Diede, Scott; Ribas, Antoni Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data. (10th December 2020) Authors: Fernandez-Penas, Pablo; Carlino, Matteo; Tsai, Katy; Atkinson, Victoria; Shaheen, Monaster; Thomas, Sajeve; Mihalcioiu, Catalin; Hagen, Tom Van; Roberts-Thomson, Rachel; Haydon, Andrew; Mant, Andrew; Butler, Marcus; Daniels, Gregory; Buchbinder, Elizabeth; Hyngstrom, John; Moller, Mecker; Puzanov... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma. (15th April 2020) Authors: Maio, Michele; Carlino, Matteo; Joshua, Anthony; McWhirter, Elaine; Ribas, Antoni; Ascierto, Paolo; Miller, Wilson; Butler, Marcus; Ferrucci, Pier; Zielinski, Robert; Vecchio, Michele Del; Gasal, Eduard; Ghori, Razi; Diede, Scott; Croydon, Elizabeth; Hamid, Omid Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗